Sexual functioning after treatment for early stage prostate cancer

被引:4
作者
Kao, J [1 ]
Jani, A [1 ]
Vijayakumar, S [1 ]
机构
[1] Univ Illinois, Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60612 USA
关键词
impotence; prostate cancer; radiotherapy; prostatectomy;
D O I
10.1023/A:1021605429339
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
With recent advances in prostate cancer detection and treatment, the vast majority of men with newly diagnosed prostate cancer can expect long-term survival. Therefore, quality of life issues become important in selecting the appropriate therapeutic approach. Sexual function can be adversely affected by the only available curative treatment modalities: radical prostatectomy, external beam radiation therapy and interstitial brachytherapy. The pathophysiology of erectile dysfunction after surgery and radiation therapy are reviewed. Reports documenting rates of erectile dysfunction after treatment among men potent prior to treatment are described. Management options for patients who become impotent after surgery or radiation therapy are outlined. Future avenues of research to decrease the rates of potency loss with modern treatment techniques are suggested.
引用
收藏
页码:239 / 260
页数:22
相关论文
共 114 条
[1]   Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: Radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities [J].
Akakura, K ;
Isaka, S ;
Akimoto, S ;
Ito, H ;
Okada, K ;
Hachiya, T ;
Yoshida, O ;
Arai, Y ;
Usami, M ;
Kotake, T ;
Tobisu, K ;
Ohashi, Y ;
Sumiyoshi, Y ;
Kakizoe, T ;
Shimazaki, J .
UROLOGY, 1999, 54 (02) :313-318
[2]  
Bagshaw M A, 1988, NCI Monogr, P47
[3]   Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study [J].
Beard, CJ ;
Propert, KJ ;
Rieker, PP ;
Clark, JA ;
Kaplan, I ;
Kantoff, PW ;
Talcott, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :223-229
[4]   Changes in sexual function after radiotherapy treatment of prostate cancer [J].
Beckendorf, V ;
Hay, M ;
Rozan, R ;
Lagrange, JL ;
NGuyen, T ;
Giraud, B .
BRITISH JOURNAL OF UROLOGY, 1996, 77 (01) :118-123
[5]  
Blasko, 1993, Semin Radiat Oncol, V3, P240, DOI 10.1016/S1053-4296(05)80121-3
[6]   Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes [J].
Blasko, JC ;
Mate, T ;
Sylvester, JE ;
Grimm, PD ;
Cavanagh, W .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :81-94
[7]   Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin [J].
Bolla, M ;
Gonzalez, D ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Gil, T ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :295-300
[8]   Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 [J].
Borghede, G ;
Sullivan, M .
QUALITY OF LIFE RESEARCH, 1996, 5 (02) :212-222
[9]  
BRENDLER C, 2002, RADICAL PROSTATECTOM
[10]   RADIATION-INDUCED DECREASE IN NITRIC-OXIDE SYNTHASE-CONTAINING NERVES IN THE RAT PENIS [J].
CARRIER, S ;
HRICAK, H ;
LEE, SS ;
BABA, K ;
MORGAN, DM ;
NUNES, L ;
ROSS, GY ;
PHILLIPS, TL ;
LUE, TF .
RADIOLOGY, 1995, 195 (01) :95-99